MyFinsight
Home
Blog
About
Cash and cash
equivalents
$23,952K
(453.42%↑ Y/Y)
Other receivables
$2,532K
(16.79%↑ Y/Y)
Prepaid expenses and
other current assets
$673K
(-34.28%↓ Y/Y)
Operating lease
right-of-use asset
$32,884K
(-18.81%↓ Y/Y)
Total current assets
$27,157K
(261.13%↑ Y/Y)
Property and equipment,
net
$11,230K
(-11.27%↓ Y/Y)
In-process research and
development
$10,256K
(0.00%↑ Y/Y)
Restricted cash
$4,120K
(-23.56%↓ Y/Y)
Goodwill
$3,490K
(0.00%↑ Y/Y)
Other assets
$813K
(-16.44%↓ Y/Y)
Total assets
$89,950K
(11.34%↑ Y/Y)
Accumulated deficit
-$542,739K
(-54.82%↓ Y/Y)
Total liabilities and
stockholders' deficit
$89,950K
(11.34%↑ Y/Y)
Total stockholders'
deficit
-$231,173K
(-232.61%↓ Y/Y)
Additional paid-in capital
$311,195K
(10.87%↑ Y/Y)
Common stock, 0.01 par
value 217,000,000...
$371K
(2.49%↑ Y/Y)
Total liabilities
$321,123K
(113.66%↑ Y/Y)
Total current
liabilities
$250,199K
(108.35%↑ Y/Y)
Term debt,
non-current
$42,024K
Operating lease
liabilities, net of current...
$25,823K
(-4.82%↓ Y/Y)
Deferred tax liability
$3,077K
(0.00%↑ Y/Y)
Convertible loan, current
$163,904K
(390.07%↑ Y/Y)
Term debt, current
$77,580K
(-1.66%↓ Y/Y)
Current portion of
operating lease...
$4,622K
(202.99%↑ Y/Y)
Accrued compensation
$2,043K
(28.98%↑ Y/Y)
Accounts payable and
accrued liabilities
$1,855K
(20.45%↑ Y/Y)
Other current
liabilities
$195K
(42.34%↑ Y/Y)
Back
Back
Balance Sheet
Armata Pharmaceuticals, Inc. (ARMP)
Armata Pharmaceuticals, Inc. (ARMP)
source: myfinsight.com